20210804_erenumab_Headache_SB_01
| Main Authors: | Bottiroli Sara, De Icco Roberto, Guaschino Elena, Allena Marta, Ghiotto Natascia, Tassorelli Cristina, Martinelli Daniele, Sances Grazia |
|---|---|
| Format: | info dataset Journal |
| Terbitan: |
, 2021
|
| Subjects: | |
| Online Access: |
https://zenodo.org/record/5163219 |
Daftar Isi:
- Dataset refers to the evaluation of psychological predictors of the outcome of 12-month of treatment with Erenumab in Chronic Migraine patients: Responders (reduction ≥ 50% in migraine days) vs Non Responders (reduction < 50% in migraine days). To this end, patients at baseline received a full psychological evaluation using The Structured Clinical Interview for DSM-5 Clinician Version (SCID-5-CV) to assess mood, anxiety, and personality disorders as well specific questionnaires to evaluate alexithymia traits, childhood traumas, and current life-event stressors. Results highlighted that the presence of current stressors, anxiety and Cluster C personality disorders represent negative predictors of treatment outcome.
- Funding: Ricerca Corrente 2017-2019, Ministry of Health (Italy)